Concordia Healthcare Corp (TSE:CXR)‘s stock had its “outperform” rating reaffirmed by investment analysts at Royal Bank Of Canada in a report released on Monday, reports. They currently have a C$18.00 target price on the stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 284.62% from the stock’s previous close.

Several other equities analysts have also recently issued reports on CXR. TD Securities decreased their price target on Concordia Healthcare Corp from C$45.00 to C$37.00 and set a “buy” rating on the stock in a report on Tuesday, June 28th. Goldman Sachs Group Inc. set a C$34.00 price target on Concordia Healthcare Corp in a report on Friday, July 22nd. Finally, CIBC cut Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a report on Monday, August 15th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of C$27.25.

Analyst Recommendations for Concordia Healthcare Corp (TSE:CXR)

Shares of Concordia Healthcare Corp (TSE:CXR) traded down 4.15% during midday trading on Monday, hitting $4.62. The company had a trading volume of 310,478 shares. The firm’s 50-day moving average is $7.86 and its 200-day moving average is $24.06. Concordia Healthcare Corp has a 12-month low of $4.52 and a 12-month high of $28.35. The firm’s market capitalization is $235.70 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Concordia Healthcare Corp Company Profile

Stock Target Prices

Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with's FREE daily email newsletter.